Everest expedition provides first evidence of effects of altitude on blood pressure
An expedition to Mount Everest by Italian researchers has shown for the first time that blood pressure monitored over a 24-hour period rises progressively as people climb to higher altitudes. The researchers also found that while a drug used for lowering blood pressure, called telmisartan, was effective in counteracting the effects of altitude up to 3400 metres, it was not effective at 5400 metres above sea level – the height of the Everest base camp.
The study is published online today (Wednesday) in the European Heart Journal [1], and its findings have implications ...



